Background Burnout rates amongst nurses have detrimental impact on job satisfaction, teamwork, and patient care. This costs millions of dollars in the healthcare system and challenges nurse leaders to address in order to keep up with the healthcare demands. Furthermore, burnout is especially relevant in our current healthcare climate, as frontline nurses have increased workload and multiple psychosocial stressors during the coronavirus disease (COVID-19) pandemic 62 . Literature also suggests that mindful self-care practices need to be reinforced in order to impact burnout long term. 41 Project7 Mindfulness Pledge© is an accessible and voluntary mindfulness tool that nurses can utilize in their individual practice to reduce burnout and does not require significant time commitment. Objective To evaluate the effectiveness of intentional self-care practices on nurse burnout and workplace environment by measuring job satisfaction and teamwork among nurses. Methods Comparisons between inpatient units on data from the National Database of Nursing Quality Indicators (NDNQI) with the Practice Environment Scale (PES), specifically on job enjoyment and teamwork, were done utilizing ANOVA. Results Results show that nurses in an inpatient unit that implemented Project7 has significantly higher job satisfaction as compared to units that did not implement Project7. Conclusions This suggests that this tool provides an effective and accessible mindfulness framework managers and directors can utilize to improve job satisfaction, teamwork, and thereby reduce burnout to create healthier work environments.
Aim:To examine the experiences of nurses and nursing assistants who participated in a mindfulness project.Background: Increased demands and fewer resources have become the norm in most health care settings. As a result, health care professionals face exceptional stress in their work environments and are vulnerable to burnout and compassion fatigue. Even more distressing, many new nurses are leaving their jobs within the first two years.Methods: Qualitative interviews were conducted with nine participants to discover their experience with the project. Results:The major theme, a process of moving from practice to praxis, is brought forth through in-depth descriptive analysis of nine individual interviews. The process occurred through three themes: fostering self-awareness and compassion; fostering other-awareness and compassion; and compelling transformation in the unit culture. Conclusions:This study develops an evidence base for incorporating and building mindfulness into health care environments at a time when there is a tremendous need for highly functioning practitioners.Implications for Nursing Management: Nurse leaders are encouraged to examine how they can support their staff in moving from practice to praxis as a part of improving professional well-being, retention, quality and safety in health care.
Two decades into the age of high-cost biotechnology medications, health care organizations are challenged to provide safe, effective treatment while managing costs. In a market lacking generic biotech drugs, health care organizations have few opportunities to negotiate reduced pricing; other strategies must be devised to manage use. Kaiser Permanente leverages its integrated health care delivery system to deploy management tools for costly therapies: evidence analysis, usage measurements, and multidisciplinary planning. Evidence-based medicine and realization of value provided by new therapies will depend on data capture and outcomes measurement, tools that are crucial to Kaiser Permanente's management of biotechnologies and effective use of members' financial resources. [Health Affairs 25, no. 5 (2006): 1340-1346 10.1377/hlthaff.25.5.1340 B i o t e c h n o l o gy d ru g introductions have expanded treatment options for many diseases during the past twenty years, a trend expected to continue. Treatment costs have also increased dramatically, because new biotech drugs carry high price tags. The difference in the current annual cost of drug treatment from a decade ago can amount to tens or even hundreds of thousands of dollars per patient per year for certain target diseases (Exhibit 1). 1 Such costs exceed most patients' ability to pay for the drugs, especially during prolonged therapy. Therefore, the market for these drugs exists primarily where insurers or health care organizations are able to spread the high costs across a large group of insured people.At Kaiser Permanente (KP) in California, biotech products have greatly increased drug costs, particularly in oncology, rheumatology, neurology, endocrinology, and dermatology. Some conditions, formerly untreatable, might now have a single, very costly treatment available. For example, KP California spends more than $10 million annually for biotech-derived enzyme replacements to treat approximately 1 3 4 0 S e p t e m b e r / O c t o b e r 2 0 0 6 P e r s p e c t i v e s
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.